An Analysis of the Classification and Therapeutic Effects of Hepatitis C Patients in Shaanxi

Gong Wei Feng; Zhang Yang Min; Li Shan

Article Contents

Article Navigation > Journal of Kunming Medical University > 2018 > 39(08): 64-68

Gong Wei Feng , Zhang Yang Min , Li Shan . An Analysis of the Classification and Therapeutic Effects of Hepatitis C Patients in Shaanxi[J]. Journal of Kunming Medical University, 2018, 39(08): 64-68.

Citation:

Gong Wei Feng , Zhang Yang Min , Li Shan . An Analysis of the Classification and Therapeutic Effects of Hepatitis C Patients in Shaanxi[J]. Journal of Kunming Medical University, 2018, 39(08): 64-68.

Gong Wei Feng , Zhang Yang Min , Li Shan . An Analysis of the Classification and Therapeutic Effects of Hepatitis C Patients in Shaanxi[J]. Journal of Kunming Medical University, 2018, 39(08): 64-68.

Citation:

PDF( 362 KB)

An Analysis of the Classification and Therapeutic Effects of Hepatitis C Patients in Shaanxi

Funds:

基金：陕西省科技厅重点研发计划基金资助项目 (2017SF-234);

Received Date: 2018-05-12

Abstract

Abstract

Objective To study the genotypes of hepatitis C patients in three large hospitals in Shanxi Province, and to analyze the results of the classification. Methods Genotypes and related disease markers of253 cases of hepatitis C positive patients in a total of 437 cases were analyzed.Results There was a significant difference in the I content of each type of bile acid receptor and HCV gene content among all HCV Classification patients (P<0.05) while there was no significant difference in the therapeutic effects of pegylated interferon and Galebavirin in different subtypes of HCV (P>0.05) . Conclusions Hepatitis C patients in Shanxi province are mainly type Ib and type II A, and there are significant differences in each type of gene content (P<0.05) . The content of I of bile acid receptor is of great significance in the judgement and treatment of the disease.Type 3 b, type 3 a and type 6 a have higher cure rates and better recovery rates, while type1 b, type 1 a and type 2 a have lower cure rates and recovery rates.The use of oral drugs makes hepatitis C treatment better.
- Hepatitis C virus,
- Genotypes,
- An Analysis of therapeutic effects

FullText(HTML)

References(18)

References

[1]甘雪梅, 李武.丙型肝炎治疗的机遇与挑战[J].昆明医科大学学报, 2014, 35 (12) :1-3.

[2]李莹, 张淑琼, 俞建昆, 等.云南汉族人群IL-10基因启动子多态性与HCV慢性感染的相关性研究[J].昆明医科大学学报, 2015, 36 (1) :15-18.

[3]中华医学会肝病学分会, 中华医学会感染病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.

[4]付汉东, 张爱华, 胡校云, 等.孝感地区丙型肝炎病毒基因分型特点与临床意义[J].中华医院感染学杂志, 2016, 26 (20) :4605-4607.

[5]林江, 温先勇, 唐敏.川南地区丙型肝炎基因型的特征及其临床价值[J].四川医学, 2016, 37 (12) :1348-1351.

[6]刘涛, 陈兆云, 张朝霞.新疆地区维族与汉族丙型肝炎患者HCV基因分型研究[J].中华医院感染学杂志, 2015, 25 (18) :4122-4124.

[7]胡大山, 赵伟, 薛蓉, 等.南京与广东两地丙型肝炎215例基因分型与感染途径分析[J].江苏医药, 2014, 40 (5) :597-598.

[8] 中华医学会肝病学分会, 中华医学会感染病学分会.丙型肝炎防治指南[J].中华肝脏病杂志, 2015, 23 (12) :906-923.

[9]尚明金, 李连友, 李连兴.赤峰地区丙肝基因分型及其临床意义分析[J].中国卫生标准管理杂志, 2017, 8 (8) :3-4.

[10]谢知兵, 周建亮, 李勇忠, 等.怀化地区丙肝基因分型分布及临床意义[J].中国现代医学杂志, 2013, 23 (11) :43-46.

[11]龚卫锋, 张养民, 张砚敏.妇科肿瘤患者血清人G蛋白胆汁酸受体1水平变化及其相关性探讨[J].陕西医学杂志, 2017, 46 (9) :1312-1313.

[12]杨永锐, 李晖, 沈凌.聚乙二醇干扰素ɑ-2a加利巴韦林治疗慢性丙型肝炎的临床观察[J].昆明医科大学学报, 2014, 35 (2) :100-104.

[13]许惠玲.标准化治疗方案联合辛伐他丁治疗慢性丙型肝炎的疗效分型[J].昆明医科大学学报, 2015, 36 (4) :137-139.

[14]杨永锐, 李晖, 沈凌, 等.失代偿期丙肝肝硬化患者并发症消除后的抗病毒治疗[J].昆明医科大学学报, 2014, 35 (1) :56-67.

[15]陈国凤.DAAs时代丙肝治疗的问题与挑战[J].医学研究杂志, 2016, 45 (4) :1-7.

[16]任姗, 陈新月.丙型肝炎相关直接抗病毒药物耐药的研究现状[J].临床肝胆病杂志, 2015, 31 (11) :1807-1812.

[17] 张玉, 徐小元.直接抗病毒药物耐药与预存耐药的研究[J].中华医学杂志, 2015, 95 (31) :2569-2571.

[18]周辛波.全球抗丙肝药物市场纵观[J].临床药物治疗杂志, 2015, 13 (6) :91.

Relative Articles(20)

Relative Articles

[1]	Kang HUANG, Zhirong ZHAO, Haiwen LI, Ti WU, Ting JIA, Lu WANG, Nihong LU, Yongrui YANG. Efficacy and Safety of Sofosbuvir/Velpatasvir with or without Ribavirin in Cirrhotic Patients with Genotype 3 Chronic Hepatitis C Infection. Journal of Kunming Medical University, 2023, 44(11): 126-134. doi: 10.12259/j.issn.2095-610X.S20231119
[2]	Yanwen XU, Xin WANG, Hua JIANG, Chenchen LIANG, Li LIU, Shenghao LI, Jianpeng GAO. Efficacy and Safety of Sofosbuvir-based Drugs for the Treatment of Patients with Chronic Hepatitis C Genotype 3： A Single Centre Real-world Retrospective Analysis. Journal of Kunming Medical University, 2022, 43(11): 124-129. doi: 10.12259/j.issn.2095-610X.S20221115
[3]	Helong CHE, Zhijin LI, Keqiang WANG, Weiming QIU, Yi CAO, Laibin LUO. Effect Analysis of Emergency Endoscopic Treatment for Anastomotic Hemorrhage after Colorectal Cancer Resection. Journal of Kunming Medical University, 2022, 43(10): 122-126. doi: 10.12259/j.issn.2095-610X.S20221032
[4]	Li-xuan YAO, Ben NIU, Wei YUE, Wen-lin ZHOU, Ya-ting ZHANG. Correlation Between Hepatitis C Virus Infection and Type 2 Diabetes Mellitus. Journal of Kunming Medical University, 2021, 42(8): 83-89. doi: 10.12259/j.issn.2095-610X.S20210815
[5]	Yong-rui YANG, Hai-wen LI, Zhi-rong ZHAO, Lu WANG, Ting JIA, Zhi-jian DONG, Xiao-fei LI, Ni-hong LU. Clinical Efficacy and Safety of Sofosbuvir and Vipatavir in the Treatment of Patients with Chronic Hepatitis C and HCV/HIV co-infection. Journal of Kunming Medical University, 2021, 42(7): 130-136. doi: 10.12259/j.issn.2095-610X.S20210722
[6]	Pu Dong , Li Xiao Fei , Yu Ting Ting , Wang Hong Ying , Zhang Run Wu , Li Li Hua , Bai Jing , Ding Cai Mei , Li Dong Ling , Yang Yong Rui . . Journal of Kunming Medical University, 2020, 41(06): 149-155.
[7]	Li Zhong Xi , Bai Jing Song , Tian Bo , Zhou Wen Jing , Liu Jun . . Journal of Kunming Medical University, 2019, 40(07): 100-105.
[8]	Li Zhong Xi , Liu Jun , Bai Jing Song , Tian Bo , Yu Min , Gu Shan Qun . . Journal of Kunming Medical University, 2019, 40(01): 92-95.
[9]	Li Zhong Xi , Liu Jun , Guan Wei , He Rong , Zhang Wei , Bai Jing Song . . Journal of Kunming Medical University, 2019, 40(08): 102-106.
[10]	Pu Dong , Yu Ting Ting , Wang Hong Ying , Li Li Hua , Zhang Run Wu , Ding Cai Mei , Bai Jing , Li Dong Ling , Li Xiao Fei . . Journal of Kunming Medical University, 2019, 40(11): 131-135.
[11]	Li Zhong Xi , Liu Jun , Bai Jing Song , Yu Min , Gao Cheng Bing . . Journal of Kunming Medical University, 2018, 39(12): 103-107.
[12]	Shi Xin Huan , Tang Rui Zhu , Liu Zi Jie , Lu Yan Zhou , Li Huan . The Changes of Hepatitis C Virus Gene Subtypes and RNA Loads in the Development of Chronic Hepatitis C Patients in Yunnan. Journal of Kunming Medical University, 2018, 39(06): 57-61.
[13]	Xu Hui Ling . . Journal of Kunming Medical University,
[14]	Yang Hua . . Journal of Kunming Medical University,
[15]	Li Wen Hong . . Journal of Kunming Medical University,
[16]	Shen Hong . . Journal of Kunming Medical University,
[17]	Li Wu . . Journal of Kunming Medical University, 2014, 35(12): 1-1.
[18]	Yang Shao Fen . . Journal of Kunming Medical University,
[19]	Li Zheng . . Journal of Kunming Medical University,
[20]	Chen Xue Song . . Journal of Kunming Medical University,